Retraction of

• RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.

  Mehra MR, Desai SS, Ruschitzka F, Patel AN.Mehra MR, et al.Lancet. 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016/S0140-6736(20)31180-6. Online ahead of print.Lancet. 2020.Retraction in:Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6.Retraction in:Lancet. 2020 Jul 18;396(10245):e2-e3. doi: 10.1016/S0140-6736(20)31528-2.PMID:32450107Free PMC article.Retracted.

Similar articles

• Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.

  The Lancet Editors.The Lancet Editors.Lancet. 2020 Jun 13;395(10240):e102. doi: 10.1016/S0140-6736(20)31290-3. Epub 2020 Jun 3.Lancet. 2020.PMID:32504543Free PMC article.No abstract available.
• CORRIGENDUM to Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 (updated to Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19).

  [No authors listed][No authors listed]Ann Pharmacother. 2020 Aug;54(8):832. doi: 10.1177/1060028020932400. Epub 2020 May 26.Ann Pharmacother. 2020.PMID:32456444No abstract available.

Cited by

• Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists.

  Mehta B, Moezinia CJ, Jannat-Khah D, Gibofsky A, Tornberg H, Pearce-Fisher D, Goodman SM, Salmon JE, Ibrahim S.Mehta B, et al.J Clin Rheumatol. 2020 Sep;26(6):224-228. doi: 10.1097/RHU.0000000000001539.J Clin Rheumatol. 2020.PMID:32694358Free PMC article.
• Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19.

  Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA.Sattui SE, et al.Expert Rev Clin Immunol. 2020 Jul;16(7):659-666. doi: 10.1080/1744666X.2020.1792778. Epub 2020 Aug 11.Expert Rev Clin Immunol. 2020.PMID:32620062Free PMC article.Review.
• Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.

  Prats-Uribe A, Sena AG, Lai LYH, Ahmed WU, Alghoul H, Alser O, Alshammari TM, Areia C, Carter W, Casajust P, Dawoud D, Golozar A, Jonnagaddala J, Mehta PP, Gong M, Morales DR, Nyberg F, Posada JD, Recalde M, Roel E, Shah K, Shah NH, Schilling LM, Subbian V, Vizcaya D, Zhang L, Zhang Y, Zhu H, Liu L, Cho J, Lynch KE, Matheny ME, You SC, Rijnbeek PR, Hripcsak G, Lane JC, Burn E, Reich C, Suchard MA, Duarte-Salles T, Kostka K, Ryan PB, Prieto-Alhambra D.Prats-Uribe A, et al.BMJ. 2021 May 11;373:n1038. doi: 10.1136/bmj.n1038.BMJ. 2021.PMID:33975825Free PMC article.
• Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments.

  Krenn M, Grisold A, Wohlfarth P, Rath J, Cetin H, Koneczny I, Zimprich F.Krenn M, et al.Front Mol Neurosci. 2020 Aug 14;13:156. doi: 10.3389/fnmol.2020.00156. eCollection 2020.Front Mol Neurosci. 2020.PMID:32922263Free PMC article.Review.
• Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.

  Martinez-Lopez A, Cuenca-Barrales C, Montero-Vilchez T, Molina-Leyva A, Arias-Santiago S.Martinez-Lopez A, et al.J Am Acad Dermatol. 2020 Dec;83(6):1738-1748. doi: 10.1016/j.jaad.2020.08.006. Epub 2020 Aug 7.J Am Acad Dermatol. 2020.PMID:32777318Free PMC article.Review.

References

Publication types

• Retraction Notice

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database